Skip to main content

Use of SPIOs for Clinical Liver Imaging

  • Chapter
Nanoparticles in Biomedical Imaging

Part of the book series: Fundamental Biomedical Technologies ((FBMT,volume 102))

Abstract

Superparamagnetic iron oxide (SPIO) particles are as MR contrast media composed of iron oxide crystals coated with dextran or carboxydextran. These particles are sequestered by phagocytic Kupffer cells in the normal reticuloendothelial system (RES), but are not retained in tumor tissue. Consequently, there are significant differences in /T2 *. 2 relaxation between normal RES tissue and tumors. This results in an increased lesion conspicuity and detectability. The introduction of SPIO has been expected to substantially increase the detectability of hepatic metastases. For focal hepatocellular lesions, it has been documented that SPIO-enhanced MR imaging exhibits slightly better diagnostic performance than dynamic helical CT in the detection of hypervascular hepatocellular carcinoma (HCC). A combination of dynamic and static MR-imaging technique using T1-and T2-imaging criteria appears to provide clinically more useful patterns of enhancement. SPIO-enhanced MR imaging also provides information useful for differential diagnosis, via enhancement of hemangiomas and RES-containing tumors. With the exploitation of rapid T2 *-sensitive sequences, SPIO-enhanced dynamic MR imaging may become comparable to gadolinium-enhanced dynamic MR imaging and dynamic studies with multi-detector-row CT. SPIO-enhanced MR imaging plays an important role in therapeutic decision-making for patients with malignant hepatic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Chambon, C., Clement, O., Le Blanche, A., Schouman-Claeys, E., Frija, G., 1993. Super-paramagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imag 11, 509–519.

    Article  CAS  Google Scholar 

  • Elizondo, G., Weissleder, R., Stark, D.D., Guerra, J., Garza, J., Fretz, C.J., Todd, L.E., Ferrucci, J.T., 1990. Hepatic cirrhosis and hepatitis: MR imaging enhanced with super-paramagnetic iron oxide. Radiology 174, 797–801

    PubMed  CAS  Google Scholar 

  • Grandin, C., Van Beers, B.E., Robert, A., Gigot, J.F., Geubel, A., Pringot, J., 1995. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 19, 412–418.

    Article  PubMed  CAS  Google Scholar 

  • Haider, M.A., Amitai, M.M., Rappaport, D.C., O’Malley, M.E., Hanbidge, A.E., Redston, M., Lockwood, G.A., Gallinger, S., 2002. Multi-detector row helical CT inpreoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner colli-mation better? Radiology 225, 137–142.

    Article  PubMed  Google Scholar 

  • Imai, Y., Murakami, T., Yoshida, S., Nishikawa, M., Ohsawa, M., Tokunaga, K., Murata, M., Shibata, K., Zushi, S., Kurokawa, M., Yonezawa, T., Kawata, S., Takamura, M., Nagano, H., Sakon, M., Monden, M., Wakasa, K., Nakamura, H., 2000. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading. Hepatology 32, 205–212.

    Article  PubMed  CAS  Google Scholar 

  • Jang, H.J., Lim, J.H., Lee, S.J., Park, C.K., Park, H.S., Do, Y.S., 2000. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology 215, 373–380.

    PubMed  CAS  Google Scholar 

  • Kanematsu, M., Matsuo, M., Yamada, Y., Semelka, R.C., Kondo, H., Goshima, S., Hoshi, H., Moriyama, N., 2003. Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging 18, 40–48.

    Article  PubMed  Google Scholar 

  • Kim, S.H., Choi, D., Kim, S.H., Lim, J.H., Lee, W.J., Kim, M.J., Lim, H.K., Lee, S.J., 2005. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 184, 1069–1076.

    PubMed  Google Scholar 

  • Kim, S.H., Choi, D., Lim, J.H., Lee, W.J., Jang, H.J., Lim, H.K., Lee, S.J., Cho, J.M., Kim, S.K., Kim, G.C., 2002a. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences. Korean J Radiol 3, 87–97.

    Article  Google Scholar 

  • Kim, J.H., Kim, M.J., Suh, S.H., Chung, J.J., Yoo, H.S., Lee, J.T., 2002b. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 15, 573–583.

    Google Scholar 

  • Kim, Y.K., Kim, C.S., Lee, Y.H., Kwak, H.S., Lee, J.M., 2004. Comparison of super-paramagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. AJR Am J Roentgenol 182, 1217–1223.

    PubMed  Google Scholar 

  • Kim, Y.K., Lee, J.M., Kim, C.S., Chung, G.H., Kim, C.Y., Kim, I.H., 2005. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 15, 220–228.

    Article  PubMed  Google Scholar 

  • Kuwatsuru, R., Brasch, R.C., Muhler, A., Mathur, A., Vexler, V.S., Rosenau, W., Mintorovitch, J., Berthezene, Y., Cohen, F., Shames, D.M., 1997. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. Radiology 202, 131–138.

    PubMed  CAS  Google Scholar 

  • Kwak, H.S., Lee, J.M., Kim, C.S., 2004. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography. Eur Radiol 14, 447–457.

    Article  PubMed  Google Scholar 

  • Lee, J.M., Kim, I.H., Kwak, H.S., Youk, J.H., Han, Y.M., Kim, C.S., 2003. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT. Korean J Radiol 4, 1–8.

    Article  PubMed  Google Scholar 

  • Lee, J.M., Kim, C.S., Youk, J.H., Lee, M.S., 2003. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Korean J Radiol 4, 9–18.

    Article  PubMed  Google Scholar 

  • Li, L., Wu, P.H., Mo, Y.X., Lin, H.G., Zheng, L., Li, J.Q., Lu, L.X., Ruan, C.M., Chen, L., 1999. CT arterial portography and CT hepatic arteriography in detection of micro liver cancer. World J Gastroenterol 5, 225–227.

    PubMed  Google Scholar 

  • Makita, O., Yamashita, Y., Arakawa, A., Nakayama, Y., Mitsuzaki, K., Ando, M., Namimoto, T., Takahashi, M., 2000. Diagnostic accuracy of helical CT arterial portography and CT hepatic arteriography for hypervascular hepatocellular carcinoma in chronic liver damage. An ROC analysis. Acta Radiol 41, 464–469.

    Article  PubMed  CAS  Google Scholar 

  • Murakami, T., Oi, H., Hori, M., Kim, T., Takahashi, S., Tomoda, K., Narumi, Y., Nakamura, H., 1997. Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma. AJR Am J Roentgenol 169, 131–135.

    PubMed  CAS  Google Scholar 

  • Montet, X., Lazeyras, F., Howarth, N., Mentha, G., Rubbia-Brandt, L., Becker, C.D., Vallee, J.P., Terrier, F., 2004. Specificity of SPIO particles for characterization of liver hemangiomas using MRI. Abdom Imag 29, 60–70.

    Article  CAS  Google Scholar 

  • Naganawa, S., Sato, C., Nakamura, T., Kumada, H., Ishigaki, T., Miura, S., Maruyama, K., Takizawa, O., 2005. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging 21, 836–840.

    Article  PubMed  Google Scholar 

  • Onishi, H., Murakami, T., Kim, T., Hori, M., Iannaccone, R., Kuwabara, M., Abe, H., Nakata, S., Osuga, K., Tomoda, K., Passariello, R., Nakamura, H., 2006. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 239, 131–138.

    Article  PubMed  Google Scholar 

  • Oudkerk, M., van den Heuvel, A.G., Wielopolski, P.A., Schmitz, P.I., Borel Rinkes, I.H., Wiggers, T., 1997. Hepatic lesions: Detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 203, 449–456.

    PubMed  CAS  Google Scholar 

  • Pauleit, D., Textor, J., Bachmann, R., Conrad, R., Flacke, S., Layer, G., Kreft, B., Schild, H., 2002. Hepatocellular carcinoma: detection with gadolinium-and ferumoxides-enhanced MR imaging of the liver. Radiology 222, 73–80.

    Article  PubMed  Google Scholar 

  • Poeckler-Schoeniger, C., Koepke, J., Gueckel, F., Sturm, J., Georgi, M., 1999. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imag 17, 383–392.

    Article  CAS  Google Scholar 

  • Reimer, P., Jahnke, N., Fiebich, M., Schima, W., Deckers, F., Marx, C., Holzknecht, N., Saini, S., 2000. Hepatic lesion detection and characterization: value of non-enhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217, 152–158.

    PubMed  CAS  Google Scholar 

  • Reimer, P., Muller, M., Marx, C., Wiedermann, D., Muller, R., Rummeny, E.J., Ebert, W., Shamsi, K., Peters, P.E., 1998. T1 effects of a bolus-injectable superparamagnetic iron oxide,SHU555A:dependence on field strength and plasma concentration—preliminary clinical experience with dynamic T1-weighted MR imaging. Radiology 209, 831–836.

    PubMed  CAS  Google Scholar 

  • Reimer, P., Tombach, B., 1998. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 8, 1198–1204.

    Article  PubMed  CAS  Google Scholar 

  • Senèterre, E., Taourel, P., Bouvier, Y., Pradel, J., Van Beers, B., Daures, J.P., Pringot, J., Mathieu, D., Bruel, J.M., 1996. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200, 785–792.

    PubMed  Google Scholar 

  • Stark, D.D., Weissleder, R., Elizondo, G., Hahn, P.F., Saini, S., Todd, L.E., Wittenberg, J., Ferrucci, J.T., 1988. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168, 297–301.

    PubMed  CAS  Google Scholar 

  • Takahama, K., Amano, Y., Hayashi, H., Ishihara, M., Kumazaki, T., 2003. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging. Abdom Imag 28, 525–530.

    Article  CAS  Google Scholar 

  • Takahara, T., Imai, Y., Yamashita, T., Yasuda, S., Nasu, S., Van Cauteren, M., 2004. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22, 275–282.

    PubMed  Google Scholar 

  • Tanaka, M., Nakashima, O., Wada, Y., Kage, M., Kojiro, M., 1996. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic lesions in the liver. Hepatology 24, 807–812.

    Article  PubMed  CAS  Google Scholar 

  • Tang, Y., Yamashita, Y., Arakawa, A., Namimoto, T., Mitsuzaki, K., Abe, Y., Katahira, K., Takahashi, M., 1999. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium-and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 172, 1547–1554.

    PubMed  CAS  Google Scholar 

  • Tanimoto, A., Kuribayashi, S., 2006. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 58, 200–216.

    Article  PubMed  Google Scholar 

  • Tanimoto, A., Oshio, K., Suematsu, M., Pouliquen, D., Stark, D.D., 2001. Relaxation effects of clustered particles. J Magn Reson Imag 14, 72–77.

    Article  CAS  Google Scholar 

  • Tanimoto, A., Pouliquen, D., Kreft, B.P., Stark, D.D., 1994. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide. J Magn Reson Imag 4, 653–657.

    Article  CAS  Google Scholar 

  • Tanimoto, A., Satoh, Y., Yuasa, Y., Jinzaki, M., Hiramatsu, K., 1997. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis. J Magn Reson Imaging 7, 120–124.

    Article  PubMed  CAS  Google Scholar 

  • Tanimoto, A., Wakabayashi, G., Shinmoto, H., Okuda, S., Kuribayashi, S., Mukai, M., 2005. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells. J Magn Reson Imag 21, 230–236.

    Article  Google Scholar 

  • Tanimoto, A., Wakabayashi, G., Shinmoto, H., Nakatsuka, S., Okuda, S., Kuribayashi, S., 2005. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography. J Gastroenterol 40, 371–380.

    Article  PubMed  Google Scholar 

  • Tanimoto, A., Yuasa, Y., Shinmoto, H., Jinzaki, M., Imai, Y., Okuda, S., Kuribayashi, S., 2002. Superparamagnetic iron oxide mediated hepatic signal change in patients with and without cirrhosis: Pulse sequence effects and Kupffer cell function. Radiology 222, 661–666.

    Article  PubMed  Google Scholar 

  • Vogl, T.J., Hammerstingl, R., Schwarz, W., Kummel, S., Muller, P.K., Balzer, T., Lauten, M.J., Balzer, J.O., Mack, M.G., Schimpfky, C., Schrem, H., Bechstein, W.O., Neuhaus, P., Felix, R., 1996. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. Invest Radiol 31, 696–708.

    Article  PubMed  CAS  Google Scholar 

  • Vogl, T.J., Hammerstingl, R., Schwarz, W., Mack, M.G., Muller, P.K., Pegios, W., Keck, H., Eibl-Eibesfeldt, A., Hoelzl, J., Woessmer, B., Bergman, C., Felix, R., 1996. Superparamagnetic iron oxide—enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198, 881–887.

    PubMed  CAS  Google Scholar 

  • Ward, J., Chen, F., Guthrie, J.A., Wilson, D., Lodge, JP., Wyatt, J.I., Robinson, P.J., 2000. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 214, 159–166.

    PubMed  CAS  Google Scholar 

  • Ward, J., Guthrie, J.A., Scott, D.J., Atchley, J., Wilson, D., Davies, M.H., Wyatt, J.I., Robinson, P.J., 2000. Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis. Radiology 216, 154–162.

    PubMed  CAS  Google Scholar 

  • Ward, J., Guthrie, J.A., Wilson, D., Arnold, P., Lodge, J.P., Toogood, G.J., Wyatt, J.I., Robinson, P.J., 2003. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging—comparison of optimized sequences. Radiology 228, 709–718.

    Article  PubMed  Google Scholar 

  • Ward, J., Naik, K.S., Guthrie, J.A., Wilson, D., Robinson, P.J., 1999. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210, 459–466.

    PubMed  CAS  Google Scholar 

  • Ward, J., Robinson, P.J., Guthrie, J.A., Downing, S., Wilson, D., Lodge, J.P., Prasad, K.R., Toogood, G.J., Wyatt, J.I., 2005. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging. Radiology 237, 170–180.

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Tanimoto, A. (2008). Use of SPIOs for Clinical Liver Imaging. In: Bulte, J.W., Modo, M.M. (eds) Nanoparticles in Biomedical Imaging. Fundamental Biomedical Technologies, vol 102. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72027-2_4

Download citation

Publish with us

Policies and ethics